| Toll, Benjamin |
NCT05541497: Varenicline for Treatment of E-cigarette Dependence |
|
|
| Completed | 2 | 40 | US | Varenicline Tartrate, Placebo | Yale University | Smoking Cessation | 09/23 | 09/23 | | |
NCT03069924: Gain-framed Messages and NRT for Lung Cancer Screening Patients |
|
|
| Completed | 2 | 367 | US | Gain-framed messaging, Unframed messaging materials | Medical University of South Carolina, National Cancer Institute (NCI) | Lung Cancer Screening, Smoking Cessation | 11/23 | 08/24 | | |
NCT04605458: Contingency Management to Promote Smoking Abstinence in Cancer Patients |
|
|
| Recruiting | N/A | 282 | US | Contingency Management, Standard Care | Medical University of South Carolina, National Cancer Institute (NCI) | Smoking Cessation | 06/25 | 06/25 | | |
| Aguiar, Renata Belfort De |
NCT03958409: Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients |
|
|
| Completed | N/A | 8 | US | measurements to evaluate metabolic bone disease, standard care | Yale University | Skeletal Anomalies, Kidney Transplant; Complications | 12/21 | 12/21 | | |
NCT03714451: Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes |
|
|
| Completed | N/A | 24 | US | onyx sorghum, whole wheat flour | Yale University, Silver Palate Kitchens Inc. | Diabetes Type 2 | 12/22 | 12/22 | | |
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes |
|
|
| Recruiting | N/A | 320 | Europe, US | Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham) | Fractyl Health Inc. | Type 2 Diabetes | 06/25 | 01/26 | | |
| Belfort, Renata De Aguiar |
NCT03958409: Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients |
|
|
| Completed | N/A | 8 | US | measurements to evaluate metabolic bone disease, standard care | Yale University | Skeletal Anomalies, Kidney Transplant; Complications | 12/21 | 12/21 | | |
